These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 3297327)

  • 41. Myasthenia gravis: a model disorder of acetylcholine receptors.
    Drachman DB
    Res Publ Assoc Res Nerv Ment Dis; 1987; 65():65-82. PubMed ID: 3330842
    [No Abstract]   [Full Text] [Related]  

  • 42. Analysis and modulation of the immune response of mice to acetylcholine receptor by anti-idiotypes.
    Souroujon MC; Barchan D; Fuchs S
    Immunol Lett; 1985; 9(6):331-6. PubMed ID: 3874156
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Myasthenia gravis: immune mechanisms and implications.
    Newsom-Davis J
    Clin Exp Neurol; 1981; 18():14-26. PubMed ID: 6984827
    [No Abstract]   [Full Text] [Related]  

  • 44. Idiotypes in myasthenia gravis.
    Lefvert AK
    Adv Neuroimmunol; 1994; 4(4):447-56. PubMed ID: 7719617
    [No Abstract]   [Full Text] [Related]  

  • 45. [Antibodies to acetylcholine receptor. Diagnosis and therapeutic interest in myasthenia gravis (author's transl)].
    de Crousaz G
    Ann Chir; 1980 Mar; 34(3):188-92. PubMed ID: 7369693
    [No Abstract]   [Full Text] [Related]  

  • 46. Role of receptor-binding antibodies and anti-idiotypic antihormone antibodies in immune regulation.
    Marullo S; Strosberg AD
    Concepts Immunopathol; 1986; 3():176-92. PubMed ID: 3036359
    [No Abstract]   [Full Text] [Related]  

  • 47. Anti-acetylcholine receptor idiotypes in myasthenia gravis analysed by rabbit anti-sera.
    Lang B; Roberts AJ; Vincent A; Newsom-Davis J
    Clin Exp Immunol; 1985 Jun; 60(3):637-44. PubMed ID: 4017289
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-idiotypic T cells in early stages of myasthenia gravis: increase in the number and prevalence correlated to clinical improvement in patients.
    Yi Q; Pirskanen R; Lefvert AK
    Scand J Immunol; 1996 Dec; 44(6):630-7. PubMed ID: 8972746
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Elimination of IgG subclasses of anti-acetylcholine receptor antibodies in myasthenic plasma by immunoadsorption to protein A.
    Szpirt W; Somnier F; Nielsen FC; Rødgaard A
    Life Support Syst; 1985; 3 Suppl 1():351-5. PubMed ID: 3916613
    [No Abstract]   [Full Text] [Related]  

  • 50. Plasmapheresis for myasthenia gravis.
    Med Lett Drugs Ther; 1979 Jul; 21(15):64. PubMed ID: 470831
    [No Abstract]   [Full Text] [Related]  

  • 51. Humoral immunity in myasthenia gravis: immunoglobulin class, affinity, and antigenic site.
    Tindall RS
    Trans Am Neurol Assoc; 1979; 104():16-8. PubMed ID: 553397
    [No Abstract]   [Full Text] [Related]  

  • 52. Monoclonal antibodies to the acetylcholine receptor by a normally functioning auto-anti-idiotypic mechanism.
    Cleveland WL; Wassermann NH; Sarangarajan R; Penn AS; Erlanger BF
    Nature; 1983 Sep 1-7; 305(5929):56-7. PubMed ID: 6604226
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The human acetylcholine receptor antibody: studies of kinetic and biochemical properties and the reaction with anti-idiotypic antibodies.
    Lefvert AK
    Ann N Y Acad Sci; 1981; 377():125-42. PubMed ID: 6951468
    [No Abstract]   [Full Text] [Related]  

  • 54. Reversion of anti-acetylcholine receptor-site antibodies to negative following thymectomy.
    Levin S; Steer CR
    Dev Med Child Neurol; 1981 Feb; 23(1):101-2. PubMed ID: 6970688
    [No Abstract]   [Full Text] [Related]  

  • 55. Idiotypes and autoimmunity.
    Roitt IM; Male DK; Cooke A; Lydyard PM
    Springer Semin Immunopathol; 1983; 6(1):51-66. PubMed ID: 6225198
    [No Abstract]   [Full Text] [Related]  

  • 56. Isolation of an antiidiotypic antibody with acetylcholine-receptor-like binding properties from myasthenia gravis patients.
    Eng H; Lefvert AK
    Ann Inst Pasteur Immunol; 1988; 139(5):569-80. PubMed ID: 3264701
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Idiotype- and anti-idiotype-reactive T lymphocytes in myasthenia gravis. Evidence for the involvement of different subpopulations of T helper lymphocytes.
    Yi Q; Lefvert AK
    J Immunol; 1994 Oct; 153(7):3353-9. PubMed ID: 8089503
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Auto-anti-idiotype: a basis for autoimmunity and a strategy for anti-receptor antibodies.
    Erlanger BF; Cleveland WL; Wassermann NH; Ku HH; Hill BL; Sarangarajan R; Rajagopalan R; Cayanis E; Edelman IS; Penn AS
    Immunol Rev; 1986 Dec; 94():23-37. PubMed ID: 3492425
    [No Abstract]   [Full Text] [Related]  

  • 59. Newborn infants to myasthenic mothers: a clinical study and an investigation of acetylcholine receptor antibodies in 17 children.
    Lefvert AK; Osterman PO
    Neurology; 1983 Feb; 33(2):133-8. PubMed ID: 6681654
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Myasthenia gravis; clinical aspects, pathophysiology and treatment].
    Oosterhuis HJ
    Ned Tijdschr Geneeskd; 1983 Sep; 127(39):1765-71. PubMed ID: 6314161
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.